caa a22 4500 475786661 CHVBK 20180406123700.0 cr unu---uuuuu 170329e20000701xx s 000 0 eng 10.1007/s004310000503 doi (NATIONALLICENCE)springer-10.1007/s004310000503 Adolescents' drug use and drug knowledge [Elektronische Daten] [Susanne Stoelben, Jutta Krappweis, Gabriele Rössler, Wilhelm Kirch] Self-medication is a common event. To use drugs correctly, a basic knowledge about drugs is required. Poor data are available about adults' drug knowledge. Furthermore, adolescents' basic drug knowledge has not been investigated. This study was designed in order to explore adolescents' drug use and knowledge and the factors that influence them. A total of 56 tenth grade students between 15-17 years of age at a secondary school in Dresden, Germany were enrolled in a pilot study by answering a self-completion questionnaire. Of adolescents, 57% took from one to six different drugs in the 2 weeks before questioning. In particular, a chronic consumption of non-opioid analgesics was found. Some 15% of adolescents took headache remedies at least several times per month. Self-acquisition occurred more often for these drugs than for any other drug group. The best score for drug knowledge was 10 out of 13 possible points and only 43% of students attained from 7 to 10 points. Astonishingly, more than two-thirds of adolescents could not describe in their own words how a medicinal agent is ingested. Female gender and a chronic drug consumption were detected as influencing factors of better drug knowledge. Conclusion The results indicate that adolescents gain drug knowledge through drug consumption and not before taking drugs. This leads to a potential risk particularly in the case of self-medication. Springer-Verlag Berlin Heidelberg, 2000 Key words Adolescence nationallicence Drugs nationallicence Self-medication nationallicence Knowledge nationallicence Health education nationallicence Stoelben Susanne Center for Clinical Trials, University Hospital Freiburg, Hugstetter Strasse 55, 79106 Freiburg, Germany e-mail: e-s-stoelben@t-online.de, stoelben@med1.ukl.uni-freiburg.de Tel.: +49-761-2707370; Fax: +49-761-2707383, DE aut Krappweis Jutta Institute of Clinical Pharmacology, Faculty of Medicine, University of Technology, Dresden, Germany, DE aut Rössler Gabriele Institute of Public Health North Rhine-Westphalia, Bielefeld, Germany, DE aut Kirch Wilhelm Institute of Clinical Pharmacology, Faculty of Medicine, University of Technology, Dresden, Germany, DE aut https://doi.org/10.1007/s004310000503 text/html Onlinezugriff via DOI 1 research-article jats NATIONALLICENCE 856 40 https://doi.org/10.1007/s004310000503 text/html Onlinezugriff via DOI NATIONALLICENCE 700 1- Stoelben Susanne Center for Clinical Trials, University Hospital Freiburg, Hugstetter Strasse 55, 79106 Freiburg, Germany e-mail: e-s-stoelben@t-online.de, stoelben@med1.ukl.uni-freiburg.de Tel.: +49-761-2707370; Fax: +49-761-2707383, DE aut NATIONALLICENCE 700 1- Krappweis Jutta Institute of Clinical Pharmacology, Faculty of Medicine, University of Technology, Dresden, Germany, DE aut NATIONALLICENCE 700 1- Rössler Gabriele Institute of Public Health North Rhine-Westphalia, Bielefeld, Germany, DE aut NATIONALLICENCE 700 1- Kirch Wilhelm Institute of Clinical Pharmacology, Faculty of Medicine, University of Technology, Dresden, Germany, DE aut Metadata rights reserved Springer special CC-BY-NC licence nationallicence BK010053 XK010053 XK010000 NATIONALLICENCE NATIONALLICENCE NL-springer